The GPR143 gene helps eye cells handle pigment in a normal way, which supports healthy visual development. If it does not work properly, pigment in the eyes may be reduced and vision can be affected, often causing involuntary eye movements, sensitivity to bright light, and blurred vision from childhood. Pathogenic variants in the GPR143 gene are a known cause of X linked ocular albinism type 1. This gene is mainly recognized in eye genetics rather than in popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this subject in more detail, you can find more in the LearnHub.
Overview
GPR143Gene function
What if the gene works
The GPR143 gene helps pigment cells manage melanosomes, the tiny packets that store melanin. This supports normal coloring in the eyes and skin and helps the retina develop and work as expected.
Risk
What if the gene does not work
Variants in the GPR143 gene can cause X linked ocular albinism, affecting eye pigmentation and visual development. People may have reduced vision, rapid eye movements, and light sensitivity, with milder or severe variants influencing how early and noticeable features are.
Treatment
What does that mean for your treatment
For people with a pathogenic or loss of function variant in the GPR143 gene, no GPR143-specific treatment or management approach is currently established, and treatment is guided by vision needs rather than a targeted drug.
Conditions associated with GPR143
Gene function
What if the gene works
In pigment cells, the GPR143 gene helps organize tiny compartments that make and store melanin, the pigment that gives color to the eyes, skin, and hair. This is especially important in the eye, where pigment cells support clear, steady vision. Understanding the GPR143 gene’s role in eye pigment cells helps explain its day to day work.
The GPR143 gene helps control melanosomes, the tiny cell compartments that make and hold melanin. It supports their normal growth, shape, and timing as pigment is produced and stored.
Inside pigment cells, this gene helps direct where melanosomes move and how they are positioned. That organization supports orderly pigment handling in the cells of the eye and skin.
In the retina’s pigment layer, the GPR143 gene helps keep pigment cell activity coordinated. This supports the normal environment that light sensing cells rely on for stable vision.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body reacts to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. At times, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GPR143 gene can change the receptor’s shape, stability, or movement within the cell, so less of it reaches melanosomes, the pigment handling compartments inside cells. Some changes mainly weaken signaling, while more disruptive variants may stop the protein from being made at all. This range helps explain how variants in the GPR143 gene affect melanosome function and why ocular albinism type 1 can vary, with less residual activity often linked to earlier or more marked vision findings.
How variants are linked to conditions
Variants in the GPR143 gene are best known for causing X-linked ocular albinism type 1. This condition mainly affects the eyes and can lead to reduced visual sharpness, involuntary eye movements, light sensitivity, and changes in normal eye development. In families with a confirmed GPR143-related diagnosis, the gene finding can confirm the cause of the eye condition. Some female carriers may have mild eye findings without the full condition.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of being human. Most do not directly affect health and simply reflect natural human diversity. For many genes, a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well described variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GPR143, risk is mainly set by the genetic change itself rather than by lifestyle. A family history of the condition and being genetically male can greatly raise the chance of having clearer eye and vision effects, while female carriers often have milder changes; there is not enough evidence to say that diet, exercise, or other habits lower risk.
Inheritance of GPR143 variants
GPR143-related ocular albinism usually follows an X-linked recessive inheritance pattern. In plain terms, how GPR143 is inherited depends on the X chromosome: males who inherit a disease-causing variant in the GPR143 gene are more likely to have the condition, while females with one changed copy are often carriers and may have few or mild signs. A carrier mother has a 50% chance of passing the variant to each child. An affected father passes the variant to all daughters and no sons.
What does my GPR143 result mean for my family?
Changes in the GPR143 gene usually follow an X-linked pattern, so family members on the mother’s side may also carry the change or be affected. Male relatives are more likely to have clear vision and eye-related symptoms, while female relatives may have no symptoms or only mild changes but can still carry the gene change. In families with a confirmed GPR143 result, siblings, mothers, sisters, and daughters can all have important testing implications.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for GPR143 variants usually uses a blood sample or cheek swab to read the GPR143 gene and look for changes linked with X linked ocular albinism. Results may identify a pathogenic variant, find no relevant change, or show a variant of uncertain significance, meaning the result is not yet clearly understood.
When should I consider getting a genetic test?
Consider testing the GPR143 gene if there is a personal or family history of ocular albinism, a condition that mainly affects eye development and vision. It can be especially helpful for boys or men with reduced vision from childhood, fast back-and-forth eye movements, or unusual eye coloring, and for female relatives who may be carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Many factors, including age, lifestyle, environment, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood along with other aspects of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, moves, or responds to a drug. That helps explain why the same medication works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way a person responds to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the GPR143 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine response, so any concerns about your health, vision, or how a medicine is affecting you are best discussed with your doctor.
History
The GPR143 gene came to medical attention through studies of families with X linked ocular albinism, a condition first recognized long before the responsible gene was identified. Initially understood only through visible traits, later recognized as tied to a specific gene, it was historically called OA1, a name still seen in older medical papers. In the 1990s, researchers mapped the condition to the X chromosome and then identified the gene itself, which marked an important step in clarifying why some boys in affected families shared similar eye findings. From these first observations, research expanded steadily. As naming systems became more standardized, OA1 was renamed the GPR143 gene, linking earlier clinical descriptions with modern genetics.